209 related articles for article (PubMed ID: 37371612)
1. CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice.
Khabipov A; Trung DN; van der Linde J; Miebach L; Lenz M; Erne F; von Bernstorff W; Schulze T; Kersting S; Bekeschus S; Partecke LI
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371612
[TBL] [Abstract][Full Text] [Related]
2. C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophages to facilitate metastatic potential after radiation.
Chiang Y; Lu LF; Tsai CL; Tsai YC; Wang CC; Hsueh FJ; Huang CY; Chen CH; Pu YS; Cheng JC
Eur J Cancer; 2024 Feb; 198():113521. PubMed ID: 38171115
[TBL] [Abstract][Full Text] [Related]
3. Tumors establish resistance to immunotherapy by regulating T
Marshall LA; Marubayashi S; Jorapur A; Jacobson S; Zibinsky M; Robles O; Hu DX; Jackson JJ; Pookot D; Sanchez J; Brovarney M; Wadsworth A; Chian D; Wustrow D; Kassner PD; Cutler G; Wong B; Brockstedt DG; Talay O
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243932
[TBL] [Abstract][Full Text] [Related]
4. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.
Maolake A; Izumi K; Shigehara K; Natsagdorj A; Iwamoto H; Kadomoto S; Takezawa Y; Machioka K; Narimoto K; Namiki M; Lin WJ; Wufuer G; Mizokami A
Oncotarget; 2017 Feb; 8(6):9739-9751. PubMed ID: 28039457
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
[TBL] [Abstract][Full Text] [Related]
8. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
9. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17.
Zhang A; Xu Y; Xu H; Ren J; Meng T; Ni Y; Zhu Q; Zhang WB; Pan YB; Jin J; Bi Y; Wu ZB; Lin S; Lou M
Theranostics; 2021; 11(8):3839-3852. PubMed ID: 33664865
[No Abstract] [Full Text] [Related]
10. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
11. Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4/STAT6 in the tumor microenvironment.
Kimura S; Noguchi H; Nanbu U; Nakayama T
Oncol Lett; 2021 May; 21(5):383. PubMed ID: 33777206
[TBL] [Abstract][Full Text] [Related]
12. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
15. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
[TBL] [Abstract][Full Text] [Related]
16. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
[TBL] [Abstract][Full Text] [Related]
17. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput chemotaxis detection method for CCR4
Magnotti EL; Chan LL; Zhu Q; Marasco WA
J Immunol Methods; 2020 Apr; 479():112747. PubMed ID: 31958449
[TBL] [Abstract][Full Text] [Related]
20. C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer.
Rapp M; Grassmann S; Chaloupka M; Layritz P; Kruger S; Ormanns S; Rataj F; Janssen KP; Endres S; Anz D; Kobold S
Oncoimmunology; 2016 Mar; 5(3):e1105428. PubMed ID: 27195186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
